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Introduction
Ischemic cardiomyopathy resulting from LV remodeling
and conversion of myocytes to scar tissue is the eventual
scenario in severe coronary disease. A candidate treatment
for this condition is therapeutic angiogenesis. A percuta-
neous transendocardial approach to therapeutic angio-
genesis in ischemic myocardium aims to: 1) achieve
locally effective concentration of therapy; 2) minimize
side-effects associated with systemic distribution; 3) min-
imize the effect of blood enzymes on genes and 4) elimi-
nate open-chest surgery and extended hospitalization.
Purpose
To: 1) explore the effectiveness of MR-fluoroscopy for tar-
geted delivery of genes in occlusive infarction; and 2) eval-
uate VEGF gene effect on MR measurements of perfusion,
infarction size and LV function.
Methods
Three days after coronary artery occlusion, the infarction
was visualized as a bright region on delayed contrast
enhanced MRI (CE-MRI) (Figure 1) and used as a target
for delivering therapy. MR fluoroscopy was used for guid-
ing the endovascular catheter and gene delivery. The deliv-
ery required 1) the catheter's tip is perpendicular to
desired injection site, 2) ectopic extraventricular beats
appeared at needle penetration of LV and 3) injection of
Dy-DTPA-BMA into sample locations of myocardium.
VEGF (n = 6) or LacZ gene (n = 6) was injected into the
border and core of CE-MR region.
Results
The signal derived from the active catheter allowed simul-
taneous visualization of the catheter and vascular wall
(Figure 1). MR Measurements. Treated, but not control,
animals showed improved LV function as shown by
increased ejection fraction and decreased LV end systolic
volume at 7–8 wks (Figure 2). At 7–8 wks, signal intensity
of infarcted myocardium in treated animals increased by
158% compared with 79% controls on first-pass per-
fusion imaging. Both groups showed a significant
decrease in the extent of contrast enhanced regions as
compared with 3 days. VEGF gene caused a 9.4% greater
reduction in the extent of the enhanced region than con-
trols. The extent of Gd-DOTA-enhanced region was 8.5 ±
0.9% in treated and 11.3 ± 0.9% in controls (P = 0.03)
and comparable to TTC.
Histopathology
At 7–8 wks infarcts were characterized by the presence of
scar tissue. Infarcts from treated and control hearts con-
tained a few scattered thick-walled arteries as demon-
strated by Masson's trichrome stain. Infarcts from treated
animals showed numerous small caliber thin-walled ves-
sels in the scar tissue. Biotinylated isolectin B4 delineated
vascular endothelial cells with brown reaction product
(Figure 3). Infarcts from VEGF gene treated showed a hap-
hazard distribution of numerous vessels within the scar.
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MR-guided transendocardial delivery of genes into occlu-
sive infarction is an effective technique for revasculariza-
tion. This new delivery approach resulted in improved
global LV function and prevented LV remodeling that oth-
erwise was noted to occur in control animals at 7–8 weeks
after occlusion. The effectiveness of this approach most
likely stems from the effect of VEGF in promoting new
blood vessels in the target.
CE-MR image (A) shows hyperenhanced infarcted myocardium as a target for delivering therapy (arrows)Figure 1
CE-MR image (A) shows hyperenhanced infarcted myocardium as a target for delivering therapy (arrows). Real time images (B, 
C) show the endovascular catheter in LV (arrows).
Changes in ejection fraction (EF) (left), end systolic (middle) and end diastolic (right) volumes after coronary occlusion in con-trol and treat d animalsFigur  2
Changes in ejection fraction (EF) (left), end systolic (middle) and end diastolic (right) volumes after coronary occlusion in con-
trol and treated animals. VEGF gene increased the EF and decreased end systolic volume. Bold = treated; Dashed = control.Page 2 of 3
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Histology of control (left) and treated (right) infarcts (I)Figure 3
Histology of control (left) and treated (right) infarcts (I). The healed infarct in treated animals contained numerous blood ves-
sels (arrows), while a comparable area from control infarcts contained very few blood vessels. Isolectin B4 localized blood ves-
sels accentuates neovascularity of treated infarcts, as compared with control. Top panels stained with Masson trichrome and 
bottom panels with isolectin B4. Calibration bars = 80 μ.
